Chison QBit 5 High-Performance Color Doppler Ultrasound

CHISON Medical Technologies Co., Ltd.

Przegląd przedsiębiorstwa

Founded in 1996, CHISON Medical Technologies Co., Ltd. has emerged as a global leader in the development and manufacturing of diagnostic ultrasound systems. Headquartered in Wuxi, Jiangsu, China, CHISON is dedicated to creating advanced medical imaging solutions. Over the past 28 years, CHISON has built a reputation for innovation and quality, continually driving advancements in healthcare technology. The company’s strong commitment to research and development has earned it recognition as a high-tech enterprise by the Jiangsu Technology Department. In 2019, CHISON became the first Chinese ultrasound company listed on the STAR Market, a major milestone that highlighted its market value, which once exceeded 5 billion CNY.

Research and Development (R&D)

CHISON’s dedication to innovation is reflected in its six R&D centers, located in China and the United States. The company's R&D headquarters has been honored as a National Competent Enterprise on Intellectual Property Rights, with over 600 intellectual properties granted in China, the EU, and the US. CHISON’s continuous focus on cutting-edge technology is further supported by China’s national 5-year R&D plan, positioning the company at the forefront of ultrasound technology. Recent innovations include the SonoEye, which won the Gold Award in the Taihu Award Design Competition, and the launch of SonoAir, the lightest portable ultrasound machine, in 2022.

Products and Market Reach

CHISON specializes in developing high-quality ultrasound systems, with a diverse product lineup including portable ultrasound devices like the SonoAir and SonoBook, as well as cart-based systems like the SonoMax and CBit. The company’s products serve a wide range of medical specialties, including radiology, cardiovascular, women’s health, and primary care. With a global presence in over 100 countries, CHISON has earned international certifications such as CMD, CE (EU), FDA (US), CSA (Canada), and KFDA (South Korea), ensuring its products meet the highest industry standards.

Wizja przyszłości

Guided by its vision of “Value Beyond Imaging,” CHISON is committed to making diagnostic imaging technologies more accessible and affordable worldwide. By continuously advancing its product offerings and expanding its international reach, CHISON aims to empower healthcare providers with confident diagnoses and efficient workflows. The company remains focused on innovation, sustainability, and contributing to the future of healthcare, impacting millions of practitioners and patients around the globe.